![](/img/cover-not-exists.png)
Long-term outcome of treatment with dacarbazine, cisplatin, interferon-α and intravenous high dose interleukin-2 in poor risk melanoma patients
Proebstle, T. M., Fuchs, T., Scheibenbogen, C., Sterry, W., Keilholz, U.Volume:
8
Journal:
Melanoma Research
DOI:
10.1097/00008390-199812000-00011
Date:
December, 1998
File:
PDF, 501 KB
1998